Literature DB >> 12927917

Quantitative liver-spleen scan using single photon emission computerized tomography (SPECT) for assessment of hepatic function in cirrhotic patients.

Eli Zuckerman1, Gleb Slobodin, Edmond Sabo, Daniel Yeshurun, Jochanan E Naschitz, David Groshar.   

Abstract

BACKGROUND/AIMS: Accurate quantitative determination of liver function is critical in cirrhotic patients in order to predict outcome, particularly in patients who undergo hepatic resection or non-hepatic surgery. As colloid uptake by perfused Kupffer cells is proportional to perfused hepatocyte mass, quantitative liver spleen scan may be used as an index of perfused hepatocyte mass. Thus, this study was conducted to evaluate quantitative single photon emission computerized tomography (SPECT) of Tc-99mm-phytate colloid uptake by the liver as a test for hepatic function in cirrhotic patients.
METHODS: Quantitative SPECT was used to measure liver volume, quantitative colloid uptake by the liver and percentage of injected dose/ml of liver tissue in cirrhotic patients (n=75), non-cirrhotic patients with chronic liver disease (n=52) and patients without liver disease (n=36).
RESULTS: Although liver volume was similar among the three groups, the cirrhotic patients had significantly lower total quantitative uptake and quantitative uptake/ml compared to groups 2 and 3 (P<0.001). Quantitative liver uptake in the cirrhotic patients was highly correlated with Child-Pugh score (r=-0.64, P<0.0001) and with indocyanine green retention at 15 min (r=-0.84, P<0.0001).
CONCLUSIONS: Quantitative SPECT of the liver may be an additional, useful, non-invasive quantitative test for assessment of hepatic function and severity of liver disease in cirrhotic patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12927917     DOI: 10.1016/s0168-8278(03)00296-4

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  10 in total

1.  Differential hepatic avoidance radiation therapy: Proof of concept in hepatocellular carcinoma patients.

Authors:  Stephen R Bowen; Jatinder Saini; Tobias R Chapman; Robert S Miyaoka; Paul E Kinahan; George A Sandison; Tony Wong; Hubert J Vesselle; Matthew J Nyflot; Smith Apisarnthanarax
Journal:  Radiother Oncol       Date:  2015-04-28       Impact factor: 6.280

2.  Clinical Utility of Biomarkers of Liver Fibrosis.

Authors:  Keyur Patel; Don C Rockey
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-01

3.  Functional imaging of radiation liver injury in a liver metastasis patient: imaging and pathologic correlation.

Authors:  Tobias R Chapman; Asangi R Kumarapeli; Matthew J Nyflot; Stephen R Bowen; Raymond S Yeung; Hubert J Vesselle; Matthew M Yeh; Smith Apisarnthanarax
Journal:  J Gastrointest Oncol       Date:  2015-06

4.  Factors affecting the quantitative liver-spleen scan in normal individuals.

Authors:  John C Hoefs; Muhammad Y Sheikh; Heather Guerrero; Norah Milne
Journal:  Dig Dis Sci       Date:  2005-02       Impact factor: 3.199

Review 5.  Solutions that enable ablative radiotherapy for large liver tumors: Fractionated dose painting, simultaneous integrated protection, motion management, and computed tomography image guidance.

Authors:  Christopher H Crane; Eugene J Koay
Journal:  Cancer       Date:  2016-03-07       Impact factor: 6.860

6.  Demonstration of intrahepatic accumulated microbubble on ultrasound represents the grade of hepatic fibrosis.

Authors:  Hiroyuki Ishibashi; Hitoshi Maruyama; Masanori Takahashi; Taro Shimada; Hidehiro Kamesaki; Keiichi Fujiwara; Fumio Imazeki; Osamu Yokosuka
Journal:  Eur Radiol       Date:  2011-12-30       Impact factor: 5.315

7.  Non-Invasive Targeted Hepatic Irradiation and SPECT/CT Functional Imaging to Study Radiation-Induced Liver Damage in Small Animal Models.

Authors:  Rafi Kabarriti; N Patrik Brodin; Hillary Yaffe; Mark Barahman; Wade R Koba; Laibin Liu; Patrik Asp; Wolfgang A Tomé; Chandan Guha
Journal:  Cancers (Basel)       Date:  2019-11-15       Impact factor: 6.639

8.  A prospective experimental study of liver fibrosis with ultrasound and its correlation with hepatic reserve function and hemodynamics.

Authors:  Yi-Lin Yang; Li Di; Yun-You Duan; Xi Liu; Jie Liu; Rui-Jing Yang; Sheng Chen; Li-Jun Yuan
Journal:  BMC Gastroenterol       Date:  2012-11-23       Impact factor: 3.067

9.  Measuring total liver function on sulfur colloid SPECT/CT for improved risk stratification and outcome prediction of hepatocellular carcinoma patients.

Authors:  Stephen R Bowen; Tobias R Chapman; Joshua Borgman; Robert S Miyaoka; Paul E Kinahan; Iris W Liou; George A Sandison; Hubert J Vesselle; Matthew J Nyflot; Smith Apisarnthanarax
Journal:  EJNMMI Res       Date:  2016-06-27       Impact factor: 3.138

10.  Programmed Death Ligand 1 Is Overexpressed in Liver Macrophages in Chronic Liver Diseases, and Its Blockade Improves the Antibacterial Activity Against Infections.

Authors:  Elisa Pose; Mar Coll; Celia Martínez-Sánchez; Zhutian Zeng; Bas G J Surewaard; Cristina Català; María Velasco-de Andrés; Juan José Lozano; Sílvia Ariño; David Fuster; Aida Niñerola-Bazán; Isabel Graupera; Érica Muñoz; Francisco Lozano; Pau Sancho-Bru; Paul Kubes; Pere Ginès
Journal:  Hepatology       Date:  2021-06-02       Impact factor: 17.425

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.